Composition and methods for optimizing health of cancer patients by the administration of sodium selenite and vitamin k3
OwnerMark Ira Simoninventor
Life of this patent
Estimating the term…
Abstract
Compositions and methods of treating carcinoma in an individual afflicted with such a condition, comprising the administration to the individual a therapeutically effective amount of a composition consisting essentially of a nutraceutically acceptable carrier and sodium selenite, with or without menadione. The administration may be sublingual and may be performed in conjunction with injection, into the solid tumor where the carcinoma is a solid tumor, or by intra-arterial catheterization or an organ specific artery where the carcinoma is organ specific, or both.
Claims28
An anti-neoplastic nutraceutical composition consisting essentially of a nutraceutically acceptable carrier and a therapeutically effective amount of one sodium selenite.
An anti-neoplastic nutraceutical composition consisting of a nutraceutically acceptable carrier and therapeutically effective amounts of sodium selenite and menadione.
The anti-neoplastic nutraceutical composition of claim 9 wherein the sodium selenite is present in an amount ranging from about 500 mcg-50 mg per tablet and the menaquinone is present in an amount ranging from about 1 mg to about 500 mg per tablet.
A method of treating carcinoma in an individual afflicted with such a condition, comprising the administration to the individual a therapeutically effective amount of a composition consisting essentially of a nutraceutically acceptable carrier and sodium selenite.
A method of treating carcinoma in an individual afflicted with such a condition, comprising the administration to the individual a therapeutically effective amount of a composition consisting essentially of a nutraceutically acceptable carrier and sodium selenite and menadione.
Dependencies are inferred from the claim text.